images-1

Roche has entered into a definitive merger agreement to acquire Poseida Therapeutics, a public clinical-stage biopharmaceutical company pioneering donor-derived CAR-T cell therapies. Based in San...

The U.S. Food and Drug Administration (FDA) has approved BridgeBio Pharma's Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for the treatment...

Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of GSK's Arexvy (respiratory syncytial virus vaccine,...